Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 995 | 2 | N/A | N/A | 0 |
| Inventories | N/A | 1 | 1 | 1 | 1 |
| TOTAL | $999 | $3 | $1 | $1 | $1 |
| Non-Current Assets | |||||
| Intangibles | 0 | 65 | 65 | 65 | 65 |
| Other Non-Current Assets | 4 | 0 | 0 | 0 | 0 |
| TOTAL | $4 | $65 | $65 | $65 | $65 |
| Total Assets | $1,003 | $67 | $65 | $65 | $65 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 300 | 0 | 0 | 0 | 0 |
| Accrued Expenses | N/A | 21 | 20 | 19 | 18 |
| TOTAL | $300 | $37 | $36 | $35 | $34 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 69 | 0 | 0 | 0 | 0 |
| TOTAL | $69 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $369 | $37 | $36 | $35 | $34 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 953 | 54,593 | 54,593 | N/A |
| Common Shares | 3 | 55 | 55 | 55 | 55 |
| Retained earnings | -316 | -25 | -26 | -25 | -23 |
| Other shareholders' equity | -350 | 0 | 0 | 0 | 0 |
| TOTAL | $633 | $30 | $29 | $30 | $31 |
| Total Liabilities And Equity | $1,003 | $67 | $65 | $65 | $65 |